| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.31 | 0.01 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.31 | 0.01 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |